Caxton Associates (New York)’s Ardelyx ARDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
– Sell
-34,971
Closed -$259K – 524
2024
Q2
$259K Buy
+34,971
New +$246K 0.01% 415
2023
Q1
– Sell
-100,605
Closed -$287K – 494
2022
Q4
$287K Buy
+100,605
New +$170K 0.02% 330
2020
Q1
– Sell
-12,287
Closed -$92K – 408
2019
Q4
$92K Buy
+12,287
New +$74.7K 0.01% 381

Other funds holding ARDX

Caxton Associates (New York)'s ARDX Position: Q3 2024 in Review

Caxton Associates (New York) sold out of Ardelyx (ARDX) in Q3 2024, closing a stake of 34,971 shares — an estimated $259K sold.

Caxton Associates (New York) first reported a position in ARDX in Q4 2019 and held it in 3 quarters. The position peaked at $287K in Q4 2022. 203 funds tracked by Wall St. Rank hold ARDX as of Q3 2024.

  • Caxton Associates (New York) reported no remaining Ardelyx position as of Q3 2024 after selling out during the quarter.
  • Caxton Associates (New York) sold 34,971 Ardelyx shares in Q3 2024, an estimated $259K.
  • Caxton Associates (New York) first reported a position in Ardelyx in Q4 2019 and held it in 3 quarters.
  • Caxton Associates (New York)'s Ardelyx position peaked at $287K in Q4 2022.
  • 203 funds tracked by Wall St. Rank held Ardelyx as of Q3 2024.

Based on Caxton Associates (New York)'s 13F filing for Q3 2024, filed 14 Nov 2024.